Clinical trial TIG-007
Study of EOS884448 alone, and in combination with iberdomide with or without dexamethasone, in participants with relapse or refractory multiple myeloma (TIG-007)
| Cancers | |
|---|---|
| Organ | Myeloma |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | iTeos |
| EudraCT Identifier | 2021-004137-36 |
| Inclusion criteria | Progression on last line of treatment, no other therapeutic option |
| Last update |